title: Highlights in NSCLC from the 2014 ASCO meeting.
authors.affiliation: University of Pittsburgh, Pittsburgh, Pennsylvani.
authors.forename: Mark A
authors.initials: MA
authors.lastname: Socinski
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000235:genetics / Q000401:mortality*; D002986:Clinical Trials as Topic; D066246:ErbB Receptors / Q000235:genetics*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000401:mortality*; D009154:Mutation / Q000235:genetics*; D015996:Survival Rate
chemical_list: D000970:Antineoplastic Agents; D066246:ErbB Receptors